Cytomedix gets funding support from Maryland Venture Fund

04/5/2013 | BeckersASC.com

Cytomedix has secured a $500,000 investment from the Maryland Venture Fund. The regenerative medicine company is currently working on its AutoloGel System, which uses platelet-rich plasma for wound healing. The company also manufactures the Angel Whole Blood Separation System, which is used in orthopedic and surgical procedures.

View Full Article in:

BeckersASC.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL